Vident Investment Advisory, LLC Novo Nordisk A S Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$155.98 - $172.65 $293,398 - $324,754
1,881 Added 19.09%
11,732 $1.9 Million
Q1 2023

May 15, 2023
BUY
$132.34 - $159.14 $450,485 - $541,712
3,404 Added 52.8%
9,851 $1.57 Million
Q4 2022

Feb 14, 2023
BUY
$102.55 - $135.33 $661,139 - $872,472
6,447 New
6,447 $872,000
Q2 2022

Aug 15, 2022
BUY
$103.24 - $121.81 $256,964 - $303,185
2,489 New
2,489 $273,000

Others Institutions Holding NVO

# of Institutions
1,955
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email